Drawing for Serial No. 86823216

USPTO serial 86823216

Serial No. 86823216

Reviewed by CopyMark Law Group

Reg. 5277114Status 701Renewal
Filing date
Status date
Registration date
Aug 29, 2017
Examiner
GARCIA, CLAUDIA
Law office
TMO LAW OFFICE 111

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with Serial No. 86823216?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Timothy T. Wang

Timothy T. Wang NI, WANG & MASSAND, PLLC8140 WALNUT HILL LN.STE. 615DALLAS, TX 75231

Goods and services

ClassDescriptionStatusFirst use
005Medicines for human purposes for the treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection; Pharmaceutical preparations for the treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection; Drugs for medical purposes, namely, drugs for the treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection; Active pharmaceutical ingredients made from raw material drug, namely, which are used for the prevention and treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection; [ Nutritional supplements; ] Veterinary preparations, namely, pain relief medication; Veterinary preparations for treatment of intestinal bacteria, parasite, infectious diseases, digestive system disease, respiratory disease, reproductive diseases; Biological preparations for veterinary purposes, namely, for domestic animals and livestock for the prevention and treatment of infectious diseases, bacterial infections, hypertension, cardiovascular disease, urinary infections, renal disease, reproductive diseases [ ; Dietary supplements for animals; Depuratives; Dental lacquer ]ACTIVEMay 9, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2023NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Sep 29, 20238.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Sep 29, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 22, 2023ES8RTEAS SECTION 8 RECEIVED—
Aug 29, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 30, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 30, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 29, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 27, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 26, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 24, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 21, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 24, 2017IUAFUSE AMENDMENT FILED—
May 24, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 16, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 26, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 24, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jan 24, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 24, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 24, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 5, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 5, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 15, 2016ALIEASSIGNED TO LIE—
Nov 30, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2016DOCKASSIGNED TO EXAMINER—
Sep 1, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 31, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 31, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 14, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2016DOCKASSIGNED TO EXAMINER—
Nov 21, 2015MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 20, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 20, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance